4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000005
Chief Financial Officer gave up 2,215 shares (to pay taxes)
- Chief Financial Officer acquired 30,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-03-01 | Grant or award | +30,900 | 80,471 | D | ||
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-03-04 | Shares withheld for taxes | −339 | $12.42 | $4,211 | 80,132 | D |
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-03-04 | Shares withheld for taxes | −405 | $13.37 | $5,414 | 79,727 | D |
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-03-05 | Shares withheld for taxes | −1,471 | $12.28 | $18,062 | 78,256 | D |
| Derivatives | |||||||
| WENTWORTH KORY JAMES Chief Financial Officer | 2024-03-01 | Grant or award · Stock Option (Right to Buy) | +46,800 | 46,800 | D | ||
Loading xslF345X05/wk-form4_1709686024.xml…